Search results
Results from the WOW.Com Content Network
As of 2008, research in this area is active. [ 27 ] Another avenue for novel anti-cancer therapies is re-engineering some of the currently used conventional antibodies like trastuzumab (targeting HER2/neu ), cetuximab and panitumumab (both targeting the EGF receptor ), using the BiTE approach.
Research continues to clarify these discrepancies. [5] The metabolic state of hypercoagulability (the tendency to form blood clots) tests are being developed. These include the evaluation of the thrombin–antithrombin complexes (TAT), low levels of the anticoagulants ATIII and protein C, but these tests are not yet widely available.
President Laura Roslin visits Galactica doctor Sherman Cottle about her cancer. Cottle determines that Roslin's cancer is far beyond surgical means of removal and suggests an aggressive chemotherapy-like treatment. Due to her mother's experiences with the treatment, Roslin refuses and decides to instead go on chamalla, an alternative means of ...
An anticoagulant, commonly known as a blood thinner, is a chemical substance that prevents or reduces the coagulation of blood, prolonging the clotting time. [1] Some occur naturally in blood-eating animals, such as leeches and mosquitoes, which help keep the bite area unclotted long enough for the animal to obtain blood.
Databases for oncogenomic research are biological databases dedicated to cancer data and oncogenomic research. They can be a primary source of cancer data, offer a certain level of analysis (processed data) or even offer online data mining .
The British Society for Haematology produces its guidelines. These guidelines are written by expert consultants and clinical scientists currently practising in the UK. The guidelines provide up-to-date evidence-based guidance on the diagnosis and treatment of haematological diseases. They provide three different styles of guidelines:
Angiogenesis inhibitors were once thought to have potential as a "silver bullet" treatment applicable to many types of cancer, but the limitations of anti-angiogenic therapy have been shown in practice. [1] Currently, angiogenesis inhibitors are recognized for their improvement of cancer immunotherapy [2] [3] by overcoming endothelial cell anergy.
In lung cancer intra-operative blood transfusion has been associated with earlier recurrence of cancer, worse survival rates and poorer outcomes after lung resection. [ 65 ] [ 66 ] Suppression of the immune system by blood transfusion has been implicated as playing a role in more than 10 different cancer types, through mechanisms involving the ...